Related Experiment Video

Updated: May 23, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

How to optimally manage growth hormone therapy: survey of Chilean pediatric endocrinologists

Roberto J García1, Alejandro Martinez-Aguayo, Verónica Mericq

  • 1Institute of Mother and Child Research, Faculty of Medicine, Universidad de Chile, Casilla, Santiago, Chile.

Hormone Research in Paediatrics
|March 22, 2012
PubMed

Insights

Pediatric endocrinologists show significant variability in managing growth hormone (GH) therapy for short stature. Standardized protocols are needed to optimize treatment outcomes and patient motivation for children receiving GH.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Clinical Management

Background:

  • Optimal management of growth failure hinges on early referral.
  • There is a lack of universal consensus among endocrinologists regarding the handling, tracking, and monitoring of growth hormone (GH) treatment.
  • Therapy monitoring protocols differ based on national prescription guidelines.

Purpose of the Study:

  • To assess the clinical management of short-stature patients undergoing GH therapy prescribed by pediatric endocrinologists in Chile.
  • To identify variations in management practices within the Chilean Endocrinology Society (SOCHED).

Main Methods:

  • An anonymous survey questionnaire was distributed to 30 pediatric endocrinologists.
  • Data on the clinical management of GH therapy for short stature was collected.

Main Results:

  • A significant variability in responses was observed across all survey questions.
  • Patients typically start GH treatment with high motivation, which is crucial for treatment success.
  • Current practices show considerable divergence in GH therapy management.

Conclusions:

  • There is a need for standardized clinical management protocols for growth hormone therapy in pediatric patients with short stature.
  • Establishing strict physician-patient communication and education within a 3-4 month follow-up period is critical for maintaining motivation and improving treatment outcomes.

More Related Videos

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...